- Home
- Internal Medicine
- Advancing Outcomes in De Novo HER2-Positive Metastatic Breast Cancer
1w3 min read
Medical Article
ASCO 2026 Highlights: De Novo HER2-Positive Metastatic Breast Cancer—Cure or Control? This session was led by Eric P. Winer, MD (Yale Cancer Center), Philip Poortmans, MD (Iridium Network), Miriam Mutebi, MD (Aga Khan University), and Amy Sanders Clark, MD, MSCE (Abramson Cancer Center, University of Pennsylvania), who explored the evolving managem

Advancing Outcomes in De Novo HER2-Positive Metastatic Breast Cancer
387 Reached4 Comments
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments

Female with History of Amenorrhoea
3103 Reached10 Comments11 Likes

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
